Additionally, Pan Y et al. [95] demonstrated the crucial role of RHOA activation for DLBCL amoeboid motility through activating STAT3, which is a critical hallmark of late-stage progressing disease. This evidence concerns the gene RHOA and diffuse large B-cell lymphoma.